Fortress Biotech Inc Pref Series A (FBIOP)vsInsmed Inc (INSM)
FBIOP
Fortress Biotech Inc Pref Series A
$13.32
+0.45%
HEALTHCARE · Cap: $73.59M
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
Smart Verdict
WallStSmart Research — data-driven comparison
Insmed Inc generates 873% more annual revenue ($606.42M vs $62.30M). FBIOP leads profitability with a 6.4% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
FBIOP
Avoid30
out of 100
Grade: F
INSM
Hold39
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 20.5% year-over-year
No standout strengths identified
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
6.4% margin — thin
Elevated debt levels
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : FBIOP
The strongest argument for FBIOP centers on Revenue Growth. Revenue growth of 20.5% demonstrates continued momentum.
Bull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bear Case : FBIOP
The primary concerns for FBIOP are EPS Growth, Market Cap, Profit Margin.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Key Dynamics to Monitor
FBIOP profiles as a growth stock while INSM is a turnaround play — different risk/reward profiles.
FBIOP carries more volatility with a beta of 1.41 — expect wider price swings.
FBIOP is growing revenue faster at 20.5% — sustainability is the question.
FBIOP generates stronger free cash flow (-6M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 30/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Fortress Biotech Inc Pref Series A
HEALTHCARE · BIOTECHNOLOGY · USA
Fortress Biotech, Inc., a biopharmaceutical company, develops and markets pharmaceutical and biotech products. The company is headquartered in New York, New York.
Visit Website →Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?